Doctor of Optometry Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Raysa Tzeng

Optometrist Roseville, CA Doctor of Optometry

NPI 1871997023 CMS profile 1280326

6750 Stanford Ranch Rd, Roseville, CA 95678

Open in the dashboard

General payments

$5,779

115 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Raysa Tzeng of Roseville, CA is reported in the CMS Open Payments database as having received $5,779 across 115 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 94th percentile of Optometrist profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $811 15
2024 General $1,269 20
2023 General $1,052 21
2022 General $771 21
2021 General $534 11
2020 General $230 11
2019 General $1,112 16

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Raysa Tzeng
  • Optometrist median
  • Middle half of Optometrist
  • National median

In program year 2025, general payments to Raysa Tzeng were reported at $811. Among 35,373 Optometrist profiles paid that year, the median was $204 and the middle half received between $87 and $464.

Show as a table
Year Raysa Tzeng Optometrist median Middle half National median
2019 $1,112 $159 $67–$371 $163
2020 $230 $72 $29–$165 $114
2021 $534 $125 $46–$292 $132
2022 $771 $162 $66–$374 $149
2023 $1,052 $177 $72–$406 $160
2024 $1,269 $188 $77–$427 $164
2025 $811 $204 $87–$464 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Johnson & Johnson Vision Care, Inc. $1,507 29 payments
  2. Alcon Vision LLC $1,425 29 payments
  3. Bausch & Lomb Americas Inc. $1,093 22 payments
  4. CooperVision Inc. $680 10 payments
  5. Bausch & Lomb, a division of Bausch Health US, LLC $396 13 payments
  6. Tarsus Pharmaceuticals, Inc. $387 5 payments
  7. Sight Sciences, Inc. $173 4 payments
  8. Glaukos Corporation $70 1 payment
  9. Optos, Inc. $28 1 payment
  10. Carl Zeiss Meditec AG $19 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $5,759 114 payments
  2. Gift $19 1 payment
Products named General payments · program years 2019–2025
  1. Acuvue $1,215 21 payments
  2. INFUSE $835 18 payments
  3. MyDay Contact Lens $666 9 payments
  4. ULTRA $326 9 payments
  5. DAILIES $295 4 payments
  6. TOTAL30 $287 9 payments
  7. XDEMVY $280 4 payments
  8. Precision 1 $213 5 payments
  9. AIR OPTIX $201 3 payments
  10. OMNI(R) SURGICAL SYSTEM (US) $173 4 payments
  11. Other $1,304 21 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

115 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Optometrist in California

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record